 Immune thrombocytopenic purpura intravenous immunoglobulin observation rapid increase platelet counts result administration intravenous immunoglobulin IVIG patient immune thrombocytopenic purpura ITP clinical studies efficacy new treatment alternative ITP new sensitive assays monoclonal antibodies platelet glycoproteins chronic ITP adults children autoimmune disorder immediate long-term effects IVIG ITP mechanisms action immunoglobulin substitution mode action IVIG Fc receptors phagocytes result antiidiotypic antibodies IVIG secondary changes complex immunologic network immunomodulatory effects basis use IVIG treatment patients immune-related disorders New aspects definition treatment ITP possible mechanisms action IVIG implications